SecBot SecBot
SECBOTREPLAY Home › Report › AXSM

AXSM · CEO Herriot Tabuteau files Form 144 to sell 49,670 shares of Axsome…

Axsome Therapeutics, Inc. · 144 filed Jun 9, 2026 at 18:01 ET

At the news

NEUTRALIMPACT 4/10

144 filed Jun 9, 2026 at 18:01 ET

CEO Herriot Tabuteau files Form 144 to sell 49,670 shares of Axsome Therapeutics (~$12.2M) under a 10b5-1 plan dated 3/10/2026. The sale is pre-planned but adds to recent insider selling activity.

  • CEO Herriot Tabuteau files to sell 49,670 shares (~$12.2M) under a 10b5-1 plan.
  • The 10b5-1 plan was established on 3/10/2026, indicating pre-planned sale.
  • Recent insider selling (30d) totals $19.9M, with this filing adding to the trend.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access